Depression and Anxiety Trial, Recruiting (NCT07565714)

Depression and Anxiety Trial, Recruiting NCT07565714 Sponsor: University of Social Sciences and Humanities, Warsaw Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07565714 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 35 years old
People who score 8 or higher on a standard anxiety questionnaire called the GAD-7, which measures how much anxiety a person has been experiencing
People who are able to recall at least two memories from childhood that involved criticism from a parent

Who may not be able to join:

People who have experienced prolonged physical or sexual abuse in their past
People who are currently receiving any form of talking therapy or taking medication for mental health
People who have been diagnosed with Post-Traumatic Stress Disorder (PTSD), assessed using standard diagnostic criteria
People who are currently experiencing problems with substance use, as identified by a screening tool called TAPS

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stanisław Karkosz, MA, SWPS University

Phone: +48 570 668 996

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07565714

Sponsor: University of Social Sciences and Humanities, Warsaw

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +48 570 668 996

More information: https://clinicaltrials.gov/study/NCT07565714

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 35 years old
People who score 8 or higher on a standard anxiety questionnaire called the GAD-7, which measures how much anxiety a person has been experiencing
People who are able to recall at least two memories from childhood that involved criticism from a parent

Who may not be able to join:

People who have experienced prolonged physical or sexual abuse in their past
People who are currently receiving any form of talking therapy or taking medication for mental health
People who have been diagnosed with Post-Traumatic Stress Disorder (PTSD), assessed using standard diagnostic criteria
People who are currently experiencing problems with substance use, as identified by a screening tool called TAPS

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Social Sciences and Humanities, Warsaw

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 June 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Generalized Anxiety Disorder DSM Scale (GAD); The Performance Failure Appraisal Inventory; Intrusive Thought Frequency (Rumination Inventory - adapted); Skin Conductance Level (SCL); Emotional Response Ratings (Subjective)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov